Wilson's Disease Clinical Trial
Official title:
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.
To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.Test various indicatorsbefore test, 4 weeks, 12 weeks and 24 weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04537377 -
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06051734 -
Early Detection of Cardiac Affection in Patients of Wilson's Disease
|
||
| Active, not recruiting |
NCT02252380 -
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
|
N/A | |
| Completed |
NCT01874028 -
A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
|
Phase 1 | |
| Recruiting |
NCT05183165 -
Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
|
N/A | |
| Completed |
NCT00212355 -
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
|
Phase 3 | |
| Recruiting |
NCT05493605 -
Cardiac Involvement in Wilson's Disease
|
N/A | |
| Recruiting |
NCT03957720 -
The Individual Therapy for Patients With Wilson's Disease
|
Early Phase 1 | |
| Recruiting |
NCT05239858 -
International Wilson's Disease Patient Registry (iWilson Registry)
|
||
| Recruiting |
NCT04012658 -
A Registered Cohort Study on Wilson's Disease
|
||
| Completed |
NCT02552628 -
WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
|
N/A | |
| Completed |
NCT06128954 -
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).
|
Phase 1 | |
| Recruiting |
NCT04212195 -
Cohort Research on Wilson's Disease
|
||
| Completed |
NCT01378182 -
Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
|
N/A |